tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
404 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.81, suggesting ARS Pharmaceuticals is a Sell.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 15.56, while ARS Pharmaceuticals’s (SPRY) share price is $17.26, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 14.60, while ARS Pharmaceuticals’s (SPRY) share price is $17.26, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Jun 27, 2025, 10:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.20
16.53
16.89
17.22
17.58
17.91
18.27
Fibonacci
16.53
16.79
16.95
17.22
17.48
17.64
17.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Jun 27, 2025, 10:01 AM
Period
Simple
Exponential
MA5
16.90Buy
17.03Buy
MA10
16.02Buy
16.30Buy
MA20
15.22Buy
15.56Buy
MA50
14.54Buy
14.60Buy
MA100
13.29Buy
13.87Buy
MA200
13.47Buy
13.43Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 16.30, while ARS Pharmaceuticals’s (SPRY) share price is $17.26, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 13.87, while ARS Pharmaceuticals’s (SPRY) share price is $17.26, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $17.26 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 14.54, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $17.26 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 13.29, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $17.26 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 13.47, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Jun 27, 2025, 10:01 AM
Name
Value
Implied Action
RSI (14)
73.36
Sell
STOCH (9,6)
89.16
Sell
STOCHRSI (14)
91.19
Sell
MACD (12,26)
0.81
Sell
ADX (14)
30.86
Neutral
Williams %R
-2.78
Sell
CCI (14)
205.09
Sell
ATR (14)
0.84
-
Ultimate Oscillator
66.02
Neutral
ROC
34.52
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 73.36, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 30.86, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 205.09, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 34.52, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 73.36, which suggests SPRY is a Sell.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.81, which suggests SPRY is a Sell.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 16.90, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 15.22, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 14.54, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 13.47, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -2.78, which suggests SPRY is a Sell.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 205.09, which suggests SPRY is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis